Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring recent patterns of migration of doctors to the United Kingdom: a mixed-methods study.

BMC health services research·2023
Same author

Drivers and barriers of international migration of doctors to and from the United Kingdom: a scoping review.

Human resources for health·2023
Same author

Systolic indentation of the left ventricular outflow tract in Eisenmenger syndrome.

Echocardiography (Mount Kisco, N.Y.)·2014
Same author

High-resolution SNP microarray investigation of copy number variations on chromosome 18 in a control cohort.

Cytogenetic and genome research·2013
Same author

Impact of urbanization on the proteome of birch pollen and its chemotactic activity on human granulocytes.

International archives of allergy and immunology·2009
Same author

Biventricular thrombi.

Echocardiography (Mount Kisco, N.Y.)·2001

Related Experiment Video

Updated: Jul 12, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

Evolving indications for permanent pacemakers.

M Bryce1, S R Spielman, A M Greenspan

  • 1Albert Einstein Medical Center, Division of Cardiovascular Diseases, 5401 Old York Road, Klein Building, Suite 363, Philadelphia, PA 19141, USA.

Annals of Internal Medicine
|June 20, 2001
PubMed
Summary

Permanent cardiac pacing offers new therapeutic options for conditions like hypertrophic obstructive cardiomyopathy, heart failure, and syncope. While promising, ongoing trials are needed to confirm long-term benefits and mortality improvements.

More Related Videos

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

Translational Rabbit Model of Chronic Cardiac Pacing
06:14

Translational Rabbit Model of Chronic Cardiac Pacing

Published on: January 6, 2023

Related Experiment Videos

Last Updated: Jul 12, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

Translational Rabbit Model of Chronic Cardiac Pacing
06:14

Translational Rabbit Model of Chronic Cardiac Pacing

Published on: January 6, 2023

Area of Science:

  • Cardiology
  • Medical Devices
  • Clinical Trials

Background:

  • Permanent cardiac pacing is increasingly indicated for various cardiovascular disorders.
  • Clinicians must be aware of evolving pacing therapies for common conditions.

Purpose of the Study:

  • To review new indications for permanent cardiac pacing.
  • To assess the clinical outcomes and therapeutic potential of pacing in specific heart conditions.

Main Methods:

  • Review of observational studies and clinical trials on cardiac pacing.
  • Analysis of pacing's efficacy in hypertrophic obstructive cardiomyopathy, dilated cardiomyopathy, heart failure, neurocardiogenic syncope, and atrial fibrillation prevention.

Main Results:

  • Observational data suggest symptomatic and hemodynamic improvement with pacing in hypertrophic obstructive cardiomyopathy.
  • Pacing shows potential as an adjunctive therapy for dilated cardiomyopathy and heart failure, though mortality benefit is unproven.
  • Rate-drop sensor algorithms may benefit neurocardiogenic syncope patients.
  • Biatrial pacing shows promise in preventing atrial fibrillation; multisite atrial pacing is investigational.

Conclusions:

  • New cardiac pacing indications offer potential clinical benefits for multiple heart conditions.
  • Further randomized trials are essential to establish long-term efficacy and mortality benefits.
  • Pacing is an evolving therapeutic strategy with promising, yet not fully established, roles in cardiovascular medicine.